Literature DB >> 26320657

Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage.

Xinyang Song1, Dai Dai1, Xiao He2, Shu Zhu1, Yikun Yao1, Hanchao Gao1, Jingjing Wang1, Fangfang Qu1, Ju Qiu1, Honglin Wang3, Xiaoxia Li4, Nan Shen5, Youcun Qian6.   

Abstract

The intestinal epithelial barrier plays a critical role in the mucosal immunity. However, it remains largely unknown how the epithelial barrier is maintained after damage. Here we show that growth factor FGF2 synergized with interleukin-17 (IL-17) to induce genes for repairing of damaged epithelium. FGF2 or IL-17 deficiency resulted in impaired epithelial proliferation, increased pro-inflammatory microbiota outgrowth, and consequently worse pathology in a DSS-induced colitis model. The dysregulated microbiota in the model induced transforming growth factor beta 1 (TGFβ1) expression, which in turn induced FGF2 expression mainly in regulatory T cells. Act1, an essential adaptor in IL-17 signaling, suppressed FGF2-induced ERK activation through binding to adaptor molecule GRB2 to interfere with its association with guanine nucleotide exchange factor SOS1. Act1 preferentially bound to IL-17 receptor complex, releasing its suppressive effect on FGF2 signaling. Thus, microbiota-driven FGF2 and IL-17 cooperate to repair the damaged intestinal epithelium through Act1-mediated direct signaling cross-talk.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26320657     DOI: 10.1016/j.immuni.2015.06.024

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  84 in total

1.  Gut-Busters: IL-17 Ain't Afraid of No IL-23.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Immunity       Date:  2015-10-20       Impact factor: 31.745

Review 2.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

Review 3.  Regulatory T cells in skin injury: At the crossroads of tolerance and tissue repair.

Authors:  Ian C Boothby; Jarish N Cohen; Michael D Rosenblum
Journal:  Sci Immunol       Date:  2020-05-01

4.  Recipient mucosal-associated invariant T cells control GVHD within the colon.

Authors:  Antiopi Varelias; Mark D Bunting; Kate L Ormerod; Motoko Koyama; Stuart D Olver; Jasmin Straube; Rachel D Kuns; Renee J Robb; Andrea S Henden; Leanne Cooper; Nancy Lachner; Kate H Gartlan; Olivier Lantz; Lars Kjer-Nielsen; Jeffrey Yw Mak; David P Fairlie; Andrew D Clouston; James McCluskey; Jamie Rossjohn; Steven W Lane; Philip Hugenholtz; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 5.  Interleukin-17: Friend or foe in organ fibrosis.

Authors:  Kritika Ramani; Partha S Biswas
Journal:  Cytokine       Date:  2019-02-14       Impact factor: 3.861

6.  Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.

Authors:  Junling Yang; Jinghong Kou; Robert Lalonde; Ken-Ichiro Fukuchi
Journal:  Brain Behav Immun       Date:  2017-05-17       Impact factor: 7.217

Review 7.  Disease tolerance and immunity in host protection against infection.

Authors:  Miguel P Soares; Luis Teixeira; Luis F Moita
Journal:  Nat Rev Immunol       Date:  2017-01-03       Impact factor: 53.106

8.  Choroidal γδ T cells in protection against retinal pigment epithelium and retinal injury.

Authors:  Zhenyang Zhao; Yuejin Liang; Yin Liu; Pei Xu; Miles J Flamme-Wiese; Deming Sun; Jiaren Sun; Robert F Mullins; Yan Chen; Jiyang Cai
Journal:  FASEB J       Date:  2017-07-20       Impact factor: 5.191

9.  [Update: enterogenic spondylarthritis].

Authors:  Elisabeth Märker-Hermann
Journal:  Z Rheumatol       Date:  2021-05-27       Impact factor: 1.372

10.  Increased Act1/IL-17R expression in Hirschsprung's disease.

Authors:  Christian Tomuschat; Anne Marie O'Donnell; David Coyle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2016-09-22       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.